[1]王海生,顾新丰,刘婷,等.口服参蝎止痛胶囊治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(03):22-26.
　WANG Haisheng,GU Xinfeng,LIU Ting,et al.A clinical study on oral application of Shenxie Zhitong(参蝎止痛)capsule for treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):22-26.
点击复制

口服参蝎止痛胶囊治疗膝骨关节炎的临床研究()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第27卷
期数:
2015年03期
页码:
22-26
栏目:
临床研究
出版日期:
2015-03-30

文章信息/Info

Title:
A clinical study on oral application of Shenxie Zhitong(参蝎止痛)capsule for treatment of knee osteoarthritis
作者:
王海生; 顾新丰; 刘婷; 何杰; 王学宗; 曹月龙; 郑昱新; 詹红生
上海中医药大学附属曙光医院,上海 201203
Author(s):
WANG Haisheng; GU Xinfeng; LIU Ting; HE Jie; WANG Xuezong; CAO Yuelong; ZHENG Yuxin; ZHAN Hongsheng
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China
关键词:
骨关节炎; 膝;  中药疗法;  治疗; 临床研究性
Keywords:
osteoarthritis; knee;  drug therapy(TCD);  therapies; investigational
摘要:
目的:观察口服参蝎止痛胶囊治疗膝骨关节炎的临床疗效和安全性。方法:将120例膝骨关节炎患者按2:1:1的比例随机分为3组,分别采用口服参蝎止痛胶囊、抗骨质增生胶囊和参蝎止痛胶囊模拟剂治疗。分别于治疗前和治疗3周后,记录并比较3组患者膝关节西安大略和麦克马斯特大学(Western Ontario and McMaster Universities,WOMAC)量表总积分及疼痛、僵硬、功能障碍积分,并比较3组患者不良反应发生情况。结果:治疗3周后,8例患者脱落。治疗前3组患者膝关节WOMAC量表总积分[(1044.43±76.04)分,(1014.93±83.13)分,(1034.03±74.10)分]、疼痛积分[(220.12 ±21.21)分,(213.87 ±22.59)分,(216.17 ±19.83)分]、僵硬积分[(66.77±10.31)分,(63.90±9.72)分,(63.67±9.46)分]及功能障碍积分[(757.55±52.43)分,(737.71±58.83)分,(754.20±52.74)分]比较,差异均无统计学意义(F=1.453,P=0.238; F=0.953,P=0.388; F=1.450,P=0.243; F=1.462,P=0.236)。治疗3周后3组患者膝关节WOMAC量表总积分[(763.02±85.42)分,(751.21±118.58)分,(964.08±70.15)分]、疼痛积分[(162.18±23.31)分,(176.54±23.62)分,(200.48±18.34)分]、僵硬积分[(43.49±8.72)分,(44.54±13.74)分,(60.93±9.66)分]及功能障碍积分[(524.00±87.48)分,(557.35±59.71)分,(699.85±51.39)分]比较,差异均有统计学意义(F=52.310,P=0.000; F=27.108,P=0.000; F=27.756,P=0.000; F=57.788,P=0.000)。进一步两两比较,参蝎止痛胶囊组WOMAC量表总积分和僵硬积分与抗骨质增生胶囊组比较,组间差异均无统计学意义(P=0.393,P=0.664); 参蝎止痛胶囊组疼痛积分及功能障碍积分均低于抗骨质增生胶囊组(P=0.006,P=0.031); 参蝎止痛胶囊组和抗骨质增生胶囊组的WOMAC量表总积分、疼痛积分、僵硬积分和功能障碍积分均低于参蝎止痛胶囊模拟剂组(P=0.000,P=0.000; P=0.000,P=0.000; P=0.000,P=0.000; P=0.000,P=0.000)。3组患者不良反应发生率比较,差异无统计学意义(χ2=0.386,P=1.000)。结论:采用口服参蝎止痛胶囊和抗骨质增生胶囊治疗膝骨关节炎,均能改善膝关节功能,缓解膝关节疼痛和僵硬,不良反应小; 但在改善膝关节疼痛及功能障碍方面,参蝎止痛胶囊优于抗骨质增生胶囊,值得临床推广应用。
Abstract:
Objective:To observe the clinical curative effect and safety of oral application of Shenxie Zhitong(参蝎止痛)capsule in the treatment of knee osteoarthritis(KOA).Methods:One hundred and twenty patients with KOA were randomly divided into 3 groups with a ratio of 2:1:1,and were treated with oral application of Shenxie Zhitong capsules,anti-hyperosteogeny capsules and mimetic Shenxie Zhitong capsules respectively.The total scores,pain scores,stiffness scores and dysfunction scores were assessed by using Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC)scale and compared between the 3 groups before the treatment and after 3-week treatment,and the incidence rate of adverse reactions was also recorded.Results:Eight patients fell off after 3-week treatment.There was no statistical difference in WOMAC aggregate scores(1044.43+/-76.04,1014.93+/-83.13,1034.03+/-74.10 points),pain scores(220.12 +/-21.21,213.87 +/-22.59,216.17 +/-19.83 points),stiffness scores(66.77+/-10.31,63.90+/-9.72,63.67+/-9.46 points)and dysfunction scores(757.55+/-52.43,737.71+/-58.83,754.20+/-52.74 points)between the 3 groups before the treatment(F=1.453,P=0.238; F=0.953,P=0.388; F=1.450,P=0.243; F=1.462,P=0.236).There was statistical difference in WOMAC aggregate scores(763.02+/-85.42,751.21+/-118.58,964.08+/-70.15 points),pain scores(162.18+/-23.31,176.54+/-23.62, 200.48+/-18.34 points),stiffness scores(43.49+/-8.72,44.54+/-13.74,60.93+/-9.66 points)and dysfunction scores(524.00+/-87.48,557.35+/-59.71,699.85+/-51.39 points)between the 3 groups after 3-week treatment(F=52.310,P=0.000; F=27.108,P=0.000; F=27.756,P=0.000; F=57.788,P=0.000).Further pairwise comparison showed that there was no statistical difference in WOMAC aggregate scores and dysfunction scores between Shenxie Zhitong capsules group and anti-hyperosteogeny capsules group(P=0.393,P=0.664).The pain scores and dysfunction scores were lower in Shenxie Zhitong capsules group compared with anti-hyperosteogeny capsules group(P=0.006,P=0.031).The WOMAC aggregate scores,pain scores,stiffness scores and dysfunction scores were lower in Shenxie Zhitong capsules group and anti-hyperosteogeny capsules group compared with mimetic Shenxie Zhitong capsule group(P=0.000,P=0.000; P=0.000,P=0.000; P=0.000,P=0.000; P=0.000,P=0.000).There was no statistical difference in the incidence rate of adverse reactions between the 3 groups(χ2=0.386,P=1.000).Conclusion:Oral application of either Shenxie Zhitong capsules or anti-hyperosteogeny capsules can improve the knee function and relieve knee pain and stiffness with less adverse reactions in the treatment of KOA.However,the former surpasses the latter in improving knee pain and dysfunction,so it is worthy of popularizing in clinic.

参考文献/References:

[1] Neogi T.The epidemiology and impact of pain in osteoarthritis[J].Osteoarthritis Cartilage,2013,21(9):1145-1153.
[2] Konttinen YT,Sillat T,Barreto G,et al.Osteoarthritis as an autoinflammatory disease caused by chondrocyte-mediated inflammatory responses[J].Arthritis Rheum,2012,64(3):613-616.
[3] 刘献祥.中医药治疗膝骨性关节炎的研究现状[J].中医正骨,2012,24(1):3-7.
[4] 王学宗,郑昱新,曹月龙,等.柔肝和化痰中药复方对膝骨关节炎患者关节功能及关节液软骨寡聚基质蛋白浓度的影响[J].中医正骨,2014,26(1):17-20.
[5] Moskowitz RW,Altman RD,Hochberg MC,et al.骨关节炎诊断与治疗[M].谢利军主译.4版.北京:人民卫生出版社,2008:264-265.
[6] Hochberg MC,AItman RD,Brandt KD,et al.Guidelines for the medical management of osteoarthritis.PartⅡ.Osteoarthritis of the knee.American College of Rheumatology[J].Arthritis Rheum,1995,38(11):1541-1546.
[7] 郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:349-353.
[8] Wang X,Cao Y,Pang J,et al.Traditional chinese herbal patch for short-term management of knee osteoarthritis:a randomized,double-blind,placebo-controlled trial[J].Evid Based Complement Alternat Med,2012,20(17):1706.
[9] Zampelis V,Ornstein E,Franzen H,et al.A simple visual analog scale for pain is as responsive as the WOMAC,the SF-36,and the EQ-5D in measuring outcomes of revision hip arthroplasty[J].Acta Orthop,2014,85(2):128-132.
[10] Papathanasiou G,Stasi S,Oikonomou L,et al.Clinimetric properties of WOMAC index in Greek knee osteoarthritis patients:comparisons with both self-reported and physical performance measures[J].Rheumatol Int,2015,35(1):115-123.
[11] 田志清,吴官保.中医药治疗膝骨性关节炎的临床研究进展[J].湖南中医杂志,2008,24(2):106-108.
[12] 陈瑛,姚政,徐隽斐,等.糖神方联合参蝎止痛胶囊治疗肝肾亏虚型糖尿病周围神经病变的临床疗效观察[J].时珍国医国药,2011,22(4):953-955.
[13] 潘峰,朱建华,郭建文.朱良春膏方运用虫类药经验[J].中医杂志,2012,53(11):912-913.
[14] 丘青中.石氏伤科虫类药物的临床应用[J].现代中西医结合杂志,2011,20(15):1883-1884.
[15] 陈小波,刘南海.三七总皂苷离子导入治疗膝骨关节炎的临床疗效观察[J].实用中西医结合临床,2010,10(6):10-11.
[16] 熊英琼,程绍民,刘端勇,等.全蝎蜈蚣在痹病治疗中的应用思路[J].辽宁中医杂志,2011,38(4):793-795.

相似文献/References:

[1]樊庆阳,任凯晶.定制3D打印切模辅助全膝关节置换术治疗 膝骨关节炎合并股骨干骨折畸形愈合[J].中医正骨,2015,27(11):37.
[2]刘晓雅,孙永强,刘国杰.主动快速康复锻炼对全膝关节置换术后关节活动度的影响[J].中医正骨,2015,27(09):73.
[3]郑春松,叶蕻芝,李西海,等.透骨消痛胶囊中补肾柔肝药和活血祛风药治疗 骨关节炎作用方式的计算机模拟比较[J].中医正骨,2015,27(07):6.
　ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(补肾柔肝)drugs versus Huoxue Qufeng(活血祛风)drugs contained in Tougu Xiaotong Jiaonang(透骨消痛胶囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):6.
[4]宋兵华,孙俊英,倪增良,等.全膝关节置换术前CT测量股骨后髁角的临床意义[J].中医正骨,2015,27(07):38.
[5]郑春松,叶蕻芝,李西海,等.独活寄生汤含药血清对白细胞介素1β诱导的 退变关节软骨细胞中基质金属蛋白酶 和环氧化酶2表达的影响[J].中医正骨,2015,27(12):1.
　ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Impact of Duhuo Jisheng Tang(独活寄生汤)medicated serum on expression of matrix metalloproteinase and cyclooxygenase 2 in degenerative articular chondrocytes induced by interleukin-1 beta[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):1.
[6]王金良,孙京涛,李玲,等.骨水泥联合螺钉修复全膝关节置换术中 胫骨平台内侧骨缺损[J].中医正骨,2015,27(12):55.
[7]冯荣,王平,李炳奇,等.铍针刺络拔罐结合中药口服治疗膝骨关节炎合并 原发性血小板增多症1例[J].中医正骨,2015,27(12):73.
[8]蔡云仙.围手术期耳穴按压联合平衡针疗法 在全膝关节置换术后镇痛中的应用[J].中医正骨,2015,27(06):41.
[9]张荣,王健.人工全膝关节置换术的围手术期心理护理[J].中医正骨,2015,27(05):77.
[10]喻长纯,杨明路,王战朝.不同手术方式治疗胫骨平台骨折畸形愈合的体会[J].中医正骨,2015,27(03):37.
[11]孟维娜,明立功,王新德,等.关节镜下清理联合腓骨近1/3段截骨治疗膝骨关节炎[J].中医正骨,2015,27(11):40.
[12]明立功,孟维娜,王新德,等.腓骨近端截骨治疗内侧间室膝骨关节炎的近期疗效观察[J].中医正骨,2015,27(10):25.
[13]张杰,王人彦,张玉柱.膝骨关节炎的治疗进展[J].中医正骨,2015,27(10):68.
[14]梁朝,蔡静怡,闫立,等.针刀疗法改善膝骨关节炎早期疼痛症状的疗效评价[J].中医正骨,2015,27(09):9.
　LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):9.
[15]王建武,党建军,李强,等.四联疗法治疗膝骨关节炎[J].中医正骨,2015,27(08):44.
[16]刘红娟,郭会利,郭树农.云克联合中药治疗膝骨关节炎的护理[J].中医正骨,2015,27(08):75.
[17]陈卫衡.探索建立系统的膝骨关节炎中医临床科研范式 和理论体系[J].中医正骨,2015,27(07):1.
[18]帅波,沈霖,杨艳萍,等.加味青娥丸治疗膝骨关节炎的作用机制研究[J].中医正骨,2015,27(07):15.
　SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):15.
[19]梅其杰,袁长深,段戡,等.壮药骨痹方烫熨联合运动疗法治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(07):27.
　MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):27.
[20]王丹辉,张燕,刘丽娟,等.重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白 关节腔注射联合中药薰洗治疗膝骨关节炎的临床研究[J].中医正骨,2015,27(07):31.
　WANG Danhui,ZHANG Yan,LIU Lijuan,et al.Clinical study on intra-articular injection of TypeⅡrecombinant human tumor necrosis factor receptor-Fc fusion protein combined with Chinese herbal steaming and washing therapy for treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):31.

备注/Memo

备注/Memo:
2014-11-13收稿 2014-12-18修回
基金项目:国家自然科学基金(81373665,81302988,81173277); 上海市教育委员会科研创新项目(11YZ64,12YZ064); “海派中医流派传承研究基地”项目(ZYSNXD-CC-HPGC-JD-001); 上海领军人才(041); 上海市科委重点科技攻关项目及科技支撑项目(11DZ1972902,13411950500,13401902502)
通讯作者:郑昱新 E-mail:sg_zyx1728@126.com
更新日期/Last Update: 2015-03-30